Soup’s corona pill reduced the risk of death and hospitalization by 50%

Soup’s corona pill reduced the risk of death and hospitalization by 50%
Soup’s corona pill reduced the risk of death and hospitalization by 50%

The pharmaceutical company Merck reports positive results in a Phase 3 clinical trial of the antiviral pill for the treatment of corona patients. The findings showed that among the 775 patients, the drug reduced the risk of hospitalization and mortality by 50%. Due to the dramatic results, the experiment was stopped earlier than expected. Pfizer and Roche are also in advanced experimental stages of an antiviral pill against Corona

Source

Soups corona pill reduced risk death hospitalization

 
For Latest Updates Follow us on Google News
 

PREV Lebanon: Al-Mayadeen team accompanies the entry of the Lebanese army into the building where snipers are holed up in Tayouneh – Al Mayadeen
NEXT Gold rises to its highest level in a month By Reuters